GeneNews Raises $1.5M in Private Placement | GenomeWeb

NEW YORK (GenomeWeb News) – GeneNews this week said that it had closed the first tranche of a private placement offering of its common shares, raising C$1.7 million (US$1.5 million).

The Toronto-based firm issued around 6.8 million common shares at a price of C$.25 per share. It plans to use the proceeds to support continued marketing of its ColonSentry test in Canada, and for pre-launch activities for the test in the US, Europe, and Asia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.